Dote, Joël W.
Banga Mingo, Virginie
Fandema, Jean
Gody, Jean C.
Mwenda, Jason M.
Esona, Mathew D.
Bowen, Michael D.
Komas, Narcisse Patrice J.
Gouandjika-Vasilache, Ionela
Waku-Kouomou, Diane
Article History
Received: 6 December 2024
Accepted: 29 April 2025
First Online: 8 May 2025
Declarations
:
: Samples were collected and tested as part of the national rotavirus surveillance programme as described in the Technical Guide for Integrated Disease Surveillance and Response in the Central African Republic, revised in 2022. The guide is validated by the Ministry of Public Health and Population and its partners and does not require consent to participate for disease surveillance programmes. Rotavirus surveillance includes genotyping of Rotavirus strains. The “Comité Éthique et Scientifique” of the “Faculté des Sciences de la Santé de l’Université de Bangui” and “Institut Pasteur de Bangui” waived the informed consent for all public health surveillance programs as recommended by World Health Organization, in compliance with the Central African regulations and the Declaration of Helsinki. This article is published with the agreement of the “Comité Éthique et Scientifique” of the “Faculté des Sciences de la Santé de l’Université de Bangui” and “Institut Pasteur de Bangui” (N°41/UB/FACSS/IPB/CES/022, 21/09/2022).
: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention and the World Health Organization (WHO). Names of specific vendors, manufacturers, or products are included for public health and informational purposes; inclusion does not imply endorsement of the vendors, manufacturers, or products by the Centers for Disease Control and Prevention or the US Department of Health and Human Services and WHO.
: Not applicable.
: The authors declare no competing interests.